Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v1-EN
Language English English
Date Updated 2022-07-01 2019-02-15
Drug Identification Number 02440202 02440202
Brand name NAT-LEVETIRACETAM NAT-LEVETIRACETAM
Common or Proper name LEVETIRACETAM Tablets LEVETIRACETAM Tablets
Company Name NATCO PHARMA (CANADA) INC NATCO PHARMA (CANADA) INC
Ingredients LEVETIRACETAM LEVETIRACETAM
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 120 120
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Requirements related to complying with good manufacturing practices. Shortage of an active ingredient.
Anticipated start date
Actual start date 2019-02-15 2019-02-15
Estimated end date Unknown
Actual end date 2022-06-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments